We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shire Plans to Acquire New River Pharmaceuticals
Shire Plans to Acquire New River Pharmaceuticals
February 20, 2007
Shire Laboratories’ plan to acquire a smaller specialty drug manufacturer, giving it full control of the marketing and manufacturing of the attention-deficit/hyperactivity disorder (ADHD) drug Vyvanse, could put it in the same market as generic Adderall XR, according to a company source.